KalVista Pharmaceuticals (KALV) Tops Q1 EPS by 14c

KalVista Pharmaceuticals (NASDAQ: KALV) reported Q1 EPS of ($0.74), $0.14 better than the analyst estimate of ($0.88).

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.

You May Also Be Interested In

• Citi turns more bullish on trucking stocks
• GE Aerospace to buy CPP for $11.75 billion in castings deal
• QNB Corp. sells $254M in securities in portfolio repositioning